E-Mail IMAGE: The clinical trial is the first step toward the team's overall goal: Developing a platform that combines radiotherapy with immunotherapy, drugs that help a patient's own immune system fight off... view more Credit: Creative commons via Pxhere A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University. MSU's Kurt Zinn, a professor of biomedical engineering, radiology and small animal clinical sciences, is leading the effort to validate an innovative radiotherapy as part of a safe, more effective and potentially less costly treatment for bladder cancer.